Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
great news from MDFZF INCREASE IN REVENUES P https://www.otcmarkets.com/stock/MDFZF/news/Medifocus-Inc-Announces-26-Increase-in-Revenue-in-Recent-Quarter-and-Positive-Cash-Flow-from-Operation-for-the-Six-Month?id=211433
they need more exposure more people need to post n tweet they had great news today people should jump on
#BreakingNews! Medifocus Inc. (#MDFZF) and (#MFS.V)
Quoted by Everett Jolly "Grossly Undervalued"
https://finance.yahoo.com/news/medifocus-inc-announces-26-increase-131500347.html
zero share volume here today? am i seeing this right?
totally agreed i cant believe no one in the otc is involved in this ticker once eyes get on it it will run to $’s the DD is more solid than the garbage tickers people get involved in...100 patents phase 3 pivotal fda approved apa breast cancer testing and they own a profit making product prolieve im long and strong with this compwny n hope people start seeing them they need more exposure and more people spreading the word
$MDFZF under valued. Check interview with John Mon & Dr Katz at upticknewswire.com. Good info
their dd is all online filings etc
Is the DD for everything published?
they still have debt as almost all otc companys plus side is they are making profits off PROLIEVE and slowly chipping away at the debt im in this stock for the long run the DD is unstoppable the patents the pivotal phase 3 fda approval all they need is exposure but the potential is great especially if that breast cancer treatment testing gets finished
that would be awesome george helped GRDO and RDGL tremendously
Medifocus financial is coming soon too...
"Hello Shareholders! We finally have our twitter account up and running! We'll be updating you with more news in the coming weeks, and financials are on the way. Thanks for the support!"
I think there is a serious connection. Both George and his GRDO are looking to fund programs and looking for Funding and Partnership opportunities.....
awesome i been in n out of CELZ for months good company hopefully mdfzf can raise their pps
I have reached out to Medifocus and they did respond. Hopefully they take advantage of PatientGain. I know my SEO so I am keeping an eye on them as they have taken over and are marketing the CaverStem.com website.
It's still early but they are doing good. Only a week in to their control of the new site.
I guess it's a buying opportunity until Medifocus ramps up marketing and others catch on.
You should do some DD on Creative Medical Technology Holdings ($CELZ)
They have a handful of patents and stock should jump a bit once CaverStem results are released.
I really like both companies.
i would call them day time they all are good at answering calls and communicating they finally made a twitter @medifocus1 the ceo wants pps to go up as well so id give them a ring that patientgain looks good and yea very strange that this isnt worth more share float etc looks good i seen the debt that thay are eliminating and they are profiting off PROLIEVE which they own and is a great product very weird that otc traders arnt engaged in this stock they would rather trade FAKE SCAM COMPANYS when this company is clearly legit over 100 patents as well and if that breast cancer pivotal study gets completed your looking at millions they just need funding to continue the Pivotal phase 3 trials Which FDA CLEARED and rarely do you see an OTC COMPANY WITH PIVOTAL PHASE 3 clearance it all goes down to exposure they need to be TWEEETED and chatted in chatrooms n people need to be made aware of the SOLID DD this company has if you got twitter tweet em put the word out
I plan to add more shares as I can. I emailed them about PatientGain which has recently been utilized by $CELZ
They specialize in medical marketing. The Medifocus site is out of date and their SEO on the Medifocus and Prolieve sites need a lot of help. Their investment would easily pay for itself with increased exposure and more sales leading to a higher PPS
the company doesnt have a lot of exposure hence the low volume..twitter is up and running and they will start giving updates if people knew about this stock it would be a lot more pps imo 100 patents fda pivotal phase 3 clearance they own PROLIEVE as well turned around their company now making profits and slowly getting out of debt
Why such low volume on this stock? Looks like it has potential. I know it has debt like most BioTechs but other than that, what is wrong??
APA 1000 FDA APPROVED FOR PIVOTAL PHASE 3 trials
their product prolieve https://prolieve.com/
$MDFZF meant to say company did a turnaround and is going to go up they own PROLIEVE making profit off it
$MDFZF Featured by Everett Jolly over at Uptick Newswire (Check out the PodCast)
Turned out to be pretty useless investment don't you think?
Glad to see there is renewed interest in the stock.
Thanks for the update
Clinical trials are not completed. Company needs time and money to do so. No bad news on clinical trial other than that.
I take it the clinical trails that were supposed to end December 2017 did not produce any real positive results or else the price would have told us so, right??
Negative profits closing the gap. Progress toward profitability. Look for news about break even and sound footing next quarter report. New product design hitting the market. Sales and revenue building approach modified with positive sales implications. Soon to get traction and attention.
Weirdest trading I have ever seen; up and down and never any significant volume....
Weirdest trading I have ever seen; up and down and never any significant volume....
Rich do you have any recent info about this company?
Ronman do you have any recent info on this company or is it history?
Anybody has any news/update etc. ????
Some life is returning to this stock.
Anybody has anything to contribute?
Any chance we are going to hear something from this company within the next five years?
Anybody has any knowledge as to how things are progressing with the company?
you still feel the same about this company?
We need some volume and investors interest. Difficult to get if you don't know what to expect at the end of the tunnel.
Any news, anyone? Do not mind waiting 2 more years but I guess there is no certainty that this is going to work. However I would think there must be some indications of success or not at this stage, not so?
He's a workaholic. 2 years is probably nothing to him. How about just make money off of their backs? You can listen to that conference yourself at VirtualInvestorConferences.com
Thanks for sharing with us. So you reckon it may pay off to wait another two years?
I just finished listening to their recorded conference call from Oct. 1. Hahahaahaa the CEO is a genius workaholic. With all their medical stuff and all his technical medical talk, you can clearly tell he was boring and did not generate hype about ifs and when. That is actually something pretty good when it comes to profits. That guy was similar to that character on Futurama the "Neutral Ambassador". Lol
People with that type of personality in this field of industry actually makes us great $$$$$$$$
2017 completion of their clinical trials also says on their website as a marker.
Phase IV expected completion in December 2017.
http://medifocusinc.com/clinical-results/
Followers
|
15
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
402
|
Created
|
08/01/11
|
Type
|
Free
|
Moderators |
Our treatment is designed with patients' needs and comfort in mind.
Medifocus, Inc. https://medifocusinc.com/ (TSXV-MFS, OTC-MDFZF) TWITTER @medifocus1 develops and commercializes minimally invasive treatment systems used in treatment of cancerous and benign tumors, and enlarged prostate, medically known as Benign Prostatic Hyperplasia (“BPH”). The Company owns two technology platforms with approximately 100 issued and pending US and international patents:
1. The “Endo-thermotherapy Platform”, and
2. The “Adaptive Phased Array Microwave Focusing Platform”.
Based on these proprietary technology platforms, the Company has developed two advanced therapeutic products: the Adaptive Phased Array (APA)-1000 system for treatment of breast cancer and the Prolieve® system for the treatment of BPH. The APA-1000 uses precisely focused and controlled microwave energy to shrink breast cancer tumors without side-effects on the surrounding tissues to produce better treatment outcomes. The Company has received regulatory approvals to complete the APA 1000’s pivotal Phase-III clinical trials, the final step before marketing approval. The U.S. FDA-approved Prolieve® System is a medical device based on endo-thermotherapy that both heats the prostate and dilates the prostatic urethra. The Prolieve® System is a minimally invasive in-office treatment option for the symptoms of enlarged prostate in men. The Prolieve® System is a revenue generating product catering to the multi billion dollar BPH market. The Company is currently focusing on marketing Prolieve® for the treatment of BPH and accelerating the APA 1000 breast cancer system’s Phase III study.
Medifocus’ strategy to capitalize on the proprietary Prolieve Thermodilation System is to generate recurring revenues through our mobile service and the sale of our disposable catheter kits.
APA-1000
The Company’s long term goal is to deploy these technology platforms to improve outcomes and standards of care in cancerous and benign tumors treatment.
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |